Company Filing History:
11 out of 837 
1 out of 3,539 
1 out of 92 
Years Active: 2003-2019
Title: Martin J Cannon: Innovator in Cancer Immunotherapy
Introduction
Martin J Cannon is a prominent inventor based in Little Rock, AR (US), known for his significant contributions to cancer immunotherapy. With a total of 13 patents, Cannon has made remarkable strides in enhancing the immune response against tumors.
Latest Patents
Cannon's latest patents include groundbreaking inventions aimed at improving cancer treatment. One notable patent focuses on the inhibition of dendritic cell-driven regulatory T cell activation and the potentiation of tumor antigen-specific T cell responses by interleukin-15 and MAP kinase inhibitor. This invention reveals that culturing dendritic cells loaded with a tumor antigen in interleukin-15 reduces Treg activity specific to the tumor antigen, thereby increasing the anti-tumor immune response. Another significant patent involves multi-epitope peptide-loaded dendritic cell immunotherapy for cancer. This patent describes peptides that bind to multiple HLA class II proteins, stimulating CD4+ T cells for cancer treatment. These peptides can be loaded onto autologous dendritic cells and infused into patients to activate T cell responses against tumor cells.
Career Highlights
Cannon has had a distinguished career, working with esteemed institutions such as the University of Arkansas and the National Institutes of Health, a component of the US Department of Health & Human Services. His work has been pivotal in advancing cancer immunotherapy and enhancing patient outcomes.
Collaborations
Throughout his career, Cannon has collaborated with notable colleagues, including Timothy J O'Brien and Alessandro D Santin. These collaborations have contributed to the development of innovative cancer treatments and have furthered research in the field.
Conclusion
Martin J Cannon's contributions to cancer immunotherapy through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to inspire advancements in cancer treatment and improve the lives of patients.